Arcturus Therapeutics Holdings Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:ARCT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Total assets 331.79 M309.27 M282.34 M271.15 M245.41 M224.31 M Total liabilities 98.03 M78.22 M57.78 M57.16 M54.05 M52.5 M Total equity 233.76 M231.05 M224.56 M213.99 M191.36 M171.81 M Total liabilities & shareholders' equities 331.79 M309.27 M282.34 M271.15 M245.41 M224.31 M Total debt 15 M————— Net debt 15 M—————

News

Broadcom, Palo Alto Networks Headline Earnings Amid A Tight Economic Calendar

Arcturus Therapeutics (ARCT) Just Flashed Golden Cross Signal: Do You Buy?

Elon Musk Backs mRNA As Moderna's Stock Soars on Cancer Vaccine Win - Moderna (NASDAQ:MRNA)

Arcturus Therapeutics (ARCT) Reports Q2 Loss, Beats Revenue Estimates

Exelixis (EXEL) Tops Q2 Earnings Estimates

PTC Therapeutics (PTCT) Beats Q2 Earnings and Revenue Estimates

Arcturus: Now That It's Come This Low, It's Time To Buy And Hold (NASDAQ:ARCT)

Arcturus Therapeutics (ARCT) Stock Jumps 5.7%: Will It Continue to Soar?

Arcturus Therapeutics Holdings Inc. (ARCT) Shareholder/Analyst Call Prepared Remarks Transcript

Arcturus Therapeutics Holdings Inc. (ARCT) Q1 2026 Earnings Call Transcript

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates